ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 134,11
-0,95%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Maxcyte Inc (MXCT)

  7. Maxcyte Inc (MXCT) Actualités

MXCT Maxcyte Inc

295,00
0,00 (0,00%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Maxcyte Inc MXCT London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 295,00 09:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
295,00 295,00 295,00 295,00 295,00
plus d'informations sur les cotations »
Secteur Industriel
PHARMACEUTICALS & BIOTECHNOLOGY

Actualités Recentes

Date Heure Source Titre
10/4/202414:05GLOBEMaxCyte to Report First Quarter 2024 Financial Results on..
10/4/202414:05UK RNSMaxCyte, Inc. Notice of Results
03/4/202408:00UK RNSMaxCyte, Inc. Total Voting Rights and Block Listing Return
02/4/202416:19ALNCNewsTRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian..
02/4/202414:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
02/4/202414:05GLOBEMaxCyte Signs Strategic Platform License with Be Biopharma..
02/4/202408:00UK RNSMaxCyte, Inc. Exercise of options and PDMR dealing
20/3/202411:16UK RNSMaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR..
20/3/202411:05UK RNSMaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR..
13/3/202412:54ALNCNewsIN BRIEF: MaxCyte loss widens in 2023 as core revenue..
13/3/202408:05UK RNSMaxCyte, Inc. Filing of form 10-K for FY ended December 31,..
13/3/202408:00UK RNSMaxCyte, Inc. Reports Q4 & FY 2023 Financial Results
12/3/202421:05UKREGMaxCyte Reports Fourth Quarter and Full Year 2023 Financial..
06/3/202409:58UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
05/3/202421:43ALNCNewsEARNINGS: dotdigital eyes rosy future; Beeks Financial turns..
05/3/202408:00UK RNSMaxCyte, Inc. Preliminary FY Results & 2024 Guidance
04/3/202422:05UKREGMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023..
01/3/202418:57UK RNSMaxCyte, Inc. Total Voting Rights
29/2/202410:21UK RNSMaxCyte, Inc. Exercise of options and PDMR dealing
26/2/202408:00UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
09/2/202414:05UK RNSMaxCyte, Inc. Notice of Results
09/2/202414:05UKREGMaxCyte to Report Fourth Quarter and Full Year 2023..
01/2/202410:24UK RNSMaxCyte, Inc. Total Voting Rights
31/1/202408:00UK RNSMaxCyte, Inc. Director/PDMR Shareholding
30/1/202415:29UK RNSMaxCyte, Inc. Holding(s) in Company
30/1/202414:58ALNCNewsIN BRIEF: MaxCyte signs licencing deal with cell therapy..
30/1/202414:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
30/1/202414:05UKREGMaxCyte and Wugen Sign Strategic Platform License to..
29/1/202418:56ALNCNewsIN BRIEF: MaxCyte chief scientific officer leaves firm
29/1/202417:52UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
29/1/202408:00UK RNSMaxCyte, Inc. Filing of Form 8-K
23/1/202419:39ALNCNewsTRADING UPDATES: Esken's Southend Airport faces further..
23/1/202414:05UKREGMaxCyte, Inc. Signing of Strategic Platform License
23/1/202414:05GLOBEMaxCyte Signs Strategic Platform License with Imugene to..
09/1/202413:18ALNCNewsMaxCyte's strategic platform licences redeem otherwise..
09/1/202408:00UKREGMaxCyte, Inc. Preliminary Unaudited Q4 and FY 2023 Results
08/1/202422:05GLOBEMaxCyte Announces Preliminary Unaudited Fourth Quarter and..
05/1/202408:00UKREGMaxCyte, Inc. Grant of Options and PDMR Dealing
03/1/202415:04ALNCNewsMaxCyte teams with Singapore-based Lion to support TCR-T..
03/1/202414:05GLOBEMaxCyte and Lion TCR form Partnership to Support Global..
03/1/202414:05UKREGMaxCyte, Inc. Signing of Strategic Platform License
02/1/202410:23UKREGMaxCyte, Inc. Total Voting Rights
02/1/202408:00GLOBEMaxCyte Confirms Appointment of Maher Masoud as President,..
02/1/202408:00UKREGMaxCyte, Inc. Confirmation of Board change
29/12/202308:00UKREGMaxCyte, Inc. Exercise of options and PDMR dealing
12/12/202316:56ALNCNewsTRADING UPDATES: Technology Minerals identifies lithium at..
12/12/202308:00UKREGMaxCyte, Inc. CEO Transition and Revenue Guidance Update
11/12/202322:05GLOBEMaxCyte Announces CEO Transition and Updates Revenue..
07/12/202310:50UKREGMaxCyte, Inc. Exercise of options and PDMR dealing
04/12/202308:00UKREGMaxCyte, Inc. Exercise of options and PDMR dealing

Dernières Valeurs Consultées

LSE
MXCT
Maxcyte
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés